One-time charges force USDL loss

Article

Imaging services provider U.S. Diagnostic of West Palm Beach, FL, last week reported that one-time charges totaling $15.1 million were the cause of an $11.9 million net loss in the company's second quarter (end-June). USDL's loss was attributable in part

Imaging services provider U.S. Diagnostic of West Palm Beach, FL, last week reported that one-time charges totaling $15.1 million were the cause of an $11.9 million net loss in the company's second quarter (end-June).

USDL's loss was attributable in part to a $4.9 million charge to settle class-action lawsuits filed earlier this year relating to revelations about one of the company's mergers and acquisitions consultants (SCAN 8/6/97). Another charge was $2.8 million spent in the quarter on a settlement with former CEO Jeffrey Goffman, who left the company in the wake of the revelations. USDL also took a $3.7 million charge for asset-impairment losses related to goodwill, and another $3.7 million in professional fees related to the shareholders' suits and investigations of the company by NASDAQ and the Securities and Exchange Commission.

The good news for USDL came on the revenue side, with the company reporting sales of $57.5 million for the second quarter, compared with $15.6 million in the same period a year ago. USDL executives said that the quarter was a difficult one, but that it represented the end of the company's recent woes. USDL shareholders seemed to agree: On the NASDAQ exchange Friday, USDL shares closed at $8.06 a share, up over 3%, while the rest of the market tanked.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.